Ensign Group Inc (ENSG)
ROA
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 209 399 | 248 179 | 240 495 | 234 193 | 224 681 | 212 950 | 204 052 | 195 786 |
| Aktywa razem | w tys. USD | 4 177 540 | 4 081 980 | 3 952 360 | 3 862 240 | 3 452 020 | 3 265 270 | 3 124 670 | 3 044 560 |
| ROA | 5,01% | 6,08% | 6,08% | 6,06% | 6,51% | 6,52% | 6,53% | 6,43% |
2023/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $209 399K ÷ $4 177 540K
= 5,01%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROA
Ensign Group Inc
ENSG
5,01%
Acadia Healthcare Company Inc
ACHC
-0,40%
Encompass Health Corp
EHC
5,73%
HCA Healthcare Inc
HCA
9,33%
National Healthcare Corp.
NHC
5,10%
Pediatrix Medical Group Inc
MD
-2,72%
Select Medical Holdings Corporation
SEM
3,05%
Tenet Healthcare Corp.
THC
2,16%
Universal Health Services, Inc.
UHS
5,14%